Endocrinopathies in thalassemia

Main Article Content

กิตติ ต่อจรัส

Abstract

-

Keywords

Article Details

Section
บทบรรณาธิการ (Editorial)

References

1. Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D,et al. Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica.2010;95:724-9.
2. Wu HP, Lin CL, Chang YC, Wu KH, Lei RL, Peng CT, et al. Survival and complication rates in patients with thalassemia major in Taiwan. Pediatr Blood Cancer. 2017;64:135-8.
3. Kanbour I, Chandra P, Soliman A, De Sanctis V, Nashwan A, Abusamaan S, et al. Severe Liver Iron Concentrations (LIC) in 24 Patients with beta-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications. MediterrJ Hematol Infect Dis. 2018;10:e2018062.
4. Soliman AT, De Sanctis V, Elalaily R, Yassin M. Insulin-like growth factor- I and factors affecting it in thalassemia major. Indian J Endocrinol Metab. 2015;19:245-51.
5. De Sanctis V, Soliman AT, Candini G, Yassin M, Raiola G, Galati MC, et al. Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major. Mediterr J Hematol Infect Dis. 2014;6:e2014074.
6. Bazi A, Sharifi-Rad J, Rostami D, Sargazi-Aval O, Safa A. Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran. J Clin Diagn Res. 2017;11:bc01-bc4.
7. Bazi A, Harati H, Khosravi-Bonjar A, Rakhshani E, Delaramnasab M. Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran. Int J Endocrinol Metab. 2018;16:e13228.
8. Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia. Endokrynol Pol. 2012;63:260-3.
9. Baldini M, Marcon A, Cassin R, Ulivieri FM, Spinelli D, Cappellini MD, et al. Beta-thalassaemia intermedia: evaluation of endocrine and bone complications. BioMed Res Int. 2014;2014:174581